NOVARTIS SAUDI LIMITED

NOVARTIS SAUDI LIMITED Company Introduction

NOVARTIS SAUDI LIMITED is the Saudi Arabian subsidiary of Novartis AG, a global healthcare company based in Switzerland. It is primarily a pharmaceutical company involved in the development, manufacturing, and marketing of innovative medicines, generic pharmaceuticals, and eye care products.

In Saudi Arabia, NOVARTIS SAUDI LIMITED operates as a comprehensive pharmaceutical entity. Its activities typically include:

* Importation and distribution of Novartis's global portfolio of medicines.

* Sales and marketing of pharmaceutical products across various therapeutic areas.

* Clinical research and development activities.

* Local packaging and potentially some manufacturing of medicines to serve the Saudi Arabian market and comply with local regulations.

Is it a factory or a trader?

NOVARTIS SAUDI LIMITED is primarily a **pharmaceutical company** with activities that encompass both **manufacturing (including local packaging)** and **trading (importation and distribution)** of its pharmaceutical products within Saudi Arabia. It is not solely a trader; it is an integrated pharmaceutical operation.

NOVARTIS SAUDI LIMITED distributes and sells a wide range of pharmaceutical products in Saudi Arabia, primarily focusing on prescription medicines across several key therapeutic areas. These include:

Oncology treatments (for various cancers)

Cardiovascular, Renal, and Metabolic disease treatments (for heart conditions, kidney diseases, and diabetes management)

Immunology, Hepatology, and Dermatology products (for autoimmune disorders, liver conditions, and skin diseases)

Neuroscience medicines (for neurological and psychiatric disorders)

Ophthalmology products (for eye care and treatments)

Respiratory disease treatments (for conditions such as asthma and chronic obstructive pulmonary disease COPD)

The specific products available are subject to local regulatory approvals and market demand within Saudi Arabia.